CIK 0000822370 · Non-accelerated filer<br>Smaller reporting company
Emmaus Life Sciences, Inc.
Sign in to watch- Ticker
- EMMA
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 870419387
- Phone
- 310-214-0065
- Business address
- 21250 HAWTHORNE BOULEVARD, SUITE 800, TORRANCE, CA, 90503
- Former names
- MYnd Analytics, Inc., CNS RESPONSE, INC., STRATIVATION, INC., SalesTactix, Inc., AGE RESEARCH INC
- 4 Derivatives Options or other derivatives
- DEF 14A Proxy Proxy Statement
- S-3 Offering Registration Statement
- S-3 Offering Registration Statement
- 8-K Event Delisting notice · Director nominations · Regulation FD disclosure
- 10-Q Report Quarterly Report
- 8-K/A Event Exhibits
- NT 10-Q Other NT 10-Q
- 8-K Event Director nominations
- 4 Open-market buy Director bought 10,000 shares at $3.44 ($34,378)
- 8-K Event Regulation FD disclosure
- 10-K Report Annual Report
- 4 Open-market buy Director bought 4,552 shares at an average $3.81 ($17,337)
- 4 Open-market buy Director bought 15,000 shares at $3.65 ($54,735)
- 8-K/A Event Executive or director change
- 8-K Event Regulation FD disclosure
- 4 Grant or award Chief Executive Officer acquired 7,500 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 7,500 shares (grant or award)
- 4 Grant or award Director acquired 7,500 shares (grant or award)
- 8-K Event Material agreement · Acquisition or sale completed · New debt or obligation · Executive or director change · Regulation FD disclosure
Page 25 of 63 · 1,250 filings